Skip to main content

Table 3 Demographic and clinical factors for patients by depression symptom outcome at 6-monthsa

From: Factors associated with response and remission from depression at 6-months of treatment in a retrospective cohort treated within an integrated care program

 

PHQ-9 < 5

PHQ-9 ≥ 5

 

PHQ-9 < 10

PHQ-9 ≥ 10

 

Δ PHQ-9 ≥ 6

Δ PHQ-9 < 6

 

Nb (%c)

Baseline PHQ-9

 Total Score, Mean (SD)

13.94 (3.95)

16.25 (4.58)

**d

14.44 (4.08)

17.14 (4.60)

**

16.61 (4.57)

15.26 (4.47)

**

 Item 9e

25 (25.00)

223 (43.30)

**

91 (31.49)

157 (48.16)

**

114 (41.16)

134 (39.64)

 

Gender

 Male

32 (32.00)

179 (34.76)

 

103 (35.64)

108 (33.13)

 

98 (35.38)

113 (33.43)

 

 Female

68 (68.00)

336 (65.24)

186 (64.36)

218 (66.87)

179 (64.62)

225 (66.57)

Ethnicity

 Hispanic/Latino

15 (15.00)

84 (16.31)

 

50 (17.30)

49 (15.03)

 

47 (16.97)

52 (15.38)

 

 Not Hispanic/Latino

77 (77.00)

381 (73.98)

215 (74.39)

243 (74.54)

203 (73.29)

255 (75.44)

 Missing

8 (8.00)

50 (9.71)

24 (8.30)

34 (10.43)

27 (9.75)

31 (9.17)

Race

 White/Caucasian

53 (53.00)

301 (58.45)

 

169 (58.48)

185 (56.75)

 

163 (58.84)

191 (55.51)

 

 Asian

9 (9.00)

45 (8.74)

 

24 (8.30)

30 (9.20)

 

24 (8.66)

30 (8.88)

 Black/African American

4 (4.00)

31 (6.02)

 

13 (4.50)

22 (6.75)

 

11 (3.97)

24 (7.10)

 Two or More Races

5 (5.00)

14 (2.72)

 

10 (3.46)

9 (2.76)

 

7 (2.53)

12 (3.55)

 Other/Unknownf

29 (29.00)

124 (24.08)

 

73 (25.26)

80 (24.54)

 

72 (25.99)

81 (23.96)

Marital Statusg

 Married/Domestic Partner

41 (41.00)

168 (32.62)

 

106 (36.68)

103 (31.60)

 

97 (35.02)

112 (33.14)

 

 Previously Married/Previous Domestic Partner

6 (6.00)

34 (6.60)

15 (5.19)

25 (7.67)

15 (5.42)

25 (7.40)

 Single

49 (49.00)

299 (58.06)

160 (55.36)

188 (57.67)

154 (55.60)

194 (57.40)

 Otherh

4 (4.00)

14 (2.72)

8 (2.77)

10 (3.07)

11 (3.97)

7 (2.07)

Age

 Age at Baseline, Mean (SD)

39.64 (14.39)

40.67 (14.91)

 

40.00 (14.43)

40.95 (15.17)

 

39.71 (14.27)

41.15 (15.24)

 

Number of Treatment Sessionsi

 Totalj, Mean (SD)

6.96 (4.02)

7.36 (4.05)

 

7.16 (4.04)

7.41 (4.04)

 

6.99 (3.94)

7.54 (4.12)

 

 With a Physiciank, Mean (SD)

2.48 (2.20)

2.88 (1.98)

 

2.65 (2.05)

2.95 (2.00)

 

2.69 (2.08)

2.91 (1.97)

 

 With a Therapistl, Mean (SD)

3.86 (4.38)

3.92 (4.33)

 

3.96 (4.43)

3.87 (4.26)

 

3.76 (4.36)

4.03 (4.31)

 

At Risk for Other Behavioral Health Conditions

 Baseline GAD-7 Score ≥ 10

61 (61.00)

373 (72.71)

*

181 (62.63)

253 (78.09)

**

200 (72.20)

234 (69.64)

 

 Baseline AUDIT-C Score ≥ 3m

31 (31.00)

197 (38.48)

 

106 (36.81)

122 (37.65)

 

97 (35.14)

131 (38.99)

 

 Baseline DAST-10 Score ≥ 3n

11 (11.00)

53 (10.29)

 

25 (8.65)

39 (11.96)

 

27 (9.75)

37 (10.95)

 

 Baseline PCL Score > 50o

13 (13.00)

161 (31.57)

**

59 (20.56)

115 (35.60)

**

83 (30.07)

91 (27.25)

 
  1. a Using 180 days (since baseline BHC) as 6-month indicator
  2. b Sample size including only patients who have at least 2 PHQ-9 scores: N = 615; PHQ-9 < 5: n = 100; PHQ-9 ≥ 5: n = 515; PHQ-9 < 10: n = 289; PHQ-9 ≥ 10: n = 326; Δ PHQ-9 ≥ 6: n = 277; Δ PHQ-9 < 6: n = 338
  3. c Percentages displayed represent “column” percentages
  4. d *p-value < 0.05, **p-value < 0.01; for continuous items, p-values represent two-sample t-test comparing mean scores between patients who have and have not reached “remission”; for categorical items, p-values represent chi-square tests under the null hypothesis of independence between “remission” status and the categorical variable
  5. e Includes any endorsement except “Not at all”
  6. f “Other/Unknown” includes: “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific Islander”, “Other”, “Unknown”
  7. g Significance test
  8. h “Other” includes: Life Partner, Significant Other, Unknown, Other, Missing
  9. i Visits to BHA in the first 6 months
  10. k Includes visits that did not indicate a provider type
  11. l Includes: Physician, Fellow
  12. m Includes: Therapist, Social Worker, Care Coordinator
  13. n Clinical cutoff is ≥3 for females, ≥ 4 for males; patients were only administered the full AUDIT-C if they did not select “never” on the first item of the AUDIT-C
  14. o Cutoff ≥3 indicates at least “moderate” symptoms; patients were only administered the DAST-10 if they screened positive on the 1-item screener
  15. p Patients were only administered the PCL if they did not select “no” for more than one item on the PC-PTSD screen
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us